Correlation Between Predictive Technology and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Predictive Technology and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Technology and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Predictive Technology Group and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Predictive Technology and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Technology with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Technology and Rigel Pharmaceuticals.
Diversification Opportunities for Predictive Technology and Rigel Pharmaceuticals
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Predictive and Rigel is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Technology Group and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Predictive Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Technology Group are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Predictive Technology i.e., Predictive Technology and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Predictive Technology and Rigel Pharmaceuticals
Given the investment horizon of 90 days Predictive Technology Group is expected to generate 20.15 times more return on investment than Rigel Pharmaceuticals. However, Predictive Technology is 20.15 times more volatile than Rigel Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.08 per unit of risk. If you would invest 0.03 in Predictive Technology Group on September 3, 2024 and sell it today you would lose (0.02) from holding Predictive Technology Group or give up 66.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 99.6% |
Values | Daily Returns |
Predictive Technology Group vs. Rigel Pharmaceuticals
Performance |
Timeline |
Predictive Technology |
Rigel Pharmaceuticals |
Predictive Technology and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Predictive Technology and Rigel Pharmaceuticals
The main advantage of trading using opposite Predictive Technology and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Technology position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.Predictive Technology vs. Viking Therapeutics | Predictive Technology vs. Terns Pharmaceuticals | Predictive Technology vs. Akero Therapeutics | Predictive Technology vs. Madrigal Pharmaceuticals |
Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |